Prices are adjusted according to historical splits.
- Today's Low:
- Today's High:
- Open Price:
- 52W Low:
- 52W High:
- Prev. Close:
- Market Cap.:
- $30.11 billion
- Book Value:
- Revenue TTM:
- $7.32 billion
- Operating Margin TTM:
- Gross Profit TTM:
- $3.08 billion
- Profit Margin:
- Return on Assets TTM:
- Return on Equity TTM:
Albemarle Corp had its IPO on 1994-02-17 under the ticker symbol ALB.
The company operates in the Basic Materials sector and Specialty Chemicals industry. Albemarle Corp has a staff strength of 7,400 employees.
Shares of Albemarle Corp opened at $212.41 at the start of the last trading session i.e. 2023-03-25.
The stocks traded within a range of $208.67 - $217.94, and closed at $217.79.
This is a +1% increase from the previous day's closing price.
A total volume of 1,588,200 shares were traded at the close of the day’s session.
In the last one week, shares of Albemarle Corp have increased by +1.48%.
Albemarle Corp's Key Ratios
Albemarle Corp has a market cap of $30.11 billion, indicating a price to book ratio of 4.3129 and a price to sales ratio of 5.0373.
In the last 12-months Albemarle Corp’s revenue was $7.32 billion with a gross profit of $3.08 billion and an EBITDA of $2.87 billion. The EBITDA ratio measures Albemarle Corp's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Albemarle Corp’s operating margin was 35.06% while its return on assets stood at 12.14% with a return of equity of 40.23%.
In Q4, Albemarle Corp’s quarterly earnings growth was a negative -4.4% while revenue growth was a positive 193.1%.
Albemarle Corp’s PE and PEG Ratio
- Forward PE
- Trailing PE
Its diluted EPS in the last 12-months stands at $22.85 per share while it has a forward price to earnings multiple of 9.7371 and a PEG multiple of 0.3163. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Albemarle Corp’s profitability.
Albemarle Corp stock is trading at a EV to sales ratio of 5.5467 and a EV to EBITDA ratio of 15.9097. Its price to sales ratio in the trailing 12-months stood at 5.0373.
Albemarle Corp stock pays annual dividends of $1.58 per share, indicating a yield of 0.64% and a payout ratio of 7.22%.
Balance sheet and cash flow metrics
- Total Assets
- $15.46 billion
- Total Liabilities
- $2.74 billion
- Operating Cash Flow
- Capital Expenditure
- $445.71 million
- Dividend Payout Ratio
Albemarle Corp ended 2023 with $15.46 billion in total assets and $0 in total liabilities. Its intangible assets were valued at $15.46 billion while shareholder equity stood at $7.98 billion.
Albemarle Corp ended 2023 with $480.77 million in deferred long-term liabilities, $2.74 billion in other current liabilities, 1172000.00 in common stock, $5.60 billion in retained earnings and $1.62 billion in goodwill. Its cash balance stood at $1.50 billion and cash and short-term investments were $1.50 billion. The company’s total short-term debt was $2,128,000 while long-term debt stood at $3.21 billion.
Albemarle Corp’s total current assets stands at $5.19 billion while long-term investments were $1.15 billion and short-term investments were $0. Its net receivables were $1.19 billion compared to accounts payable of $2.05 billion and inventory worth $2.08 billion.
In 2023, Albemarle Corp's operating cash flow was $-609340000.00 while its capital expenditure stood at $445.71 million.
Comparatively, Albemarle Corp paid $0.07 in dividends in 2023.
Other key metrics
- Current Trading Price
- 52-Week High
- 52-Week Low
- Analyst Target Price
Albemarle Corp stock is currently trading at $217.79 per share. It touched a 52-week high of $334.0168 and a 52-week low of $334.0168. Analysts tracking the stock have a 12-month average target price of $314.24.
Its 50-day moving average was $251.77 and 200-day moving average was $253.1 The short ratio stood at 2.97 indicating a short percent outstanding of 0%.
Around 19.1% of the company’s stock are held by insiders while 8680.8% are held by institutions.
Frequently Asked Questions About Albemarle Corp
Similar Industry Stocks (Specialty Chemicals)
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties and reagents, such as butyllithium and lithium aluminum hydride for use in lithium batteries for consumer electronics and electric vehicles, high performance greases, thermoplastic elastomers for car tires, rubber soles, plastic bottles, catalysts for chemical reactions, organic synthesis processes in the areas of steroid chemistry and vitamins, life sciences, pharmaceutical industry, and other markets. It also provides cesium products for the chemical and pharmaceutical industries; zirconium, barium, and titanium products for pyrotechnical applications that include airbag initiators; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services. The Bromine segment offers bromine and bromine-based products used in fire safety solutions; specialty chemicals, including elemental bromine, alkyl and inorganic bromides, brominated powdered activated carbon, and other bromine fine chemicals for use in chemical synthesis, oil and gas well drilling and completion fluids, mercury control, water purification, beef and poultry processing, and other industrial applications; and other specialty chemicals, such as tertiary amines for surfactants, biocides, disinfectants, and sanitizers. The Catalysts segment provides hydroprocessing, isomerization, and akylation catalysts; fluidized catalytic cracking catalysts and additives; and organometallics and curatives. The company serves the energy storage, petroleum refining, consumer electronics, construction, automotive, lubricants, pharmaceuticals, and crop protection markets. Albemarle Corporation was founded in 1887 and is headquartered in Charlotte, North Carolina.